{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:32:17Z","timestamp":1792801937936,"version":"4.5.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fund for Scientific Research Flanders","award":["G.0431.12N and G.0440.12N"],"award-info":[{"award-number":["G.0431.12N and G.0440.12N"]}]},{"name":"Interuniversity Attraction Poles Programme","award":["P7\/16"],"award-info":[{"award-number":["P7\/16"]}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["577668"],"award-info":[{"award-number":["577668"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ALS Liga"},{"name":"European Community's Health Seventh Framework Programme","award":["FP7\/2007-2013"],"award-info":[{"award-number":["FP7\/2007-2013"]}]},{"DOI":"10.13039\/100006402","name":"ALS Therapy Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000971","name":"Amyotrophic Lateral Sclerosis Association","doi-asserted-by":"publisher","award":["14-LGCA-181"],"award-info":[{"award-number":["14-LGCA-181"]}],"id":[{"id":"10.13039\/100000971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009281","name":"Fondation Thierry Latran","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009281","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Opening the Future - KU Leuven","id":[{"id":"https:\/\/ror.org\/05f950310","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Een Hart voor ALS"},{"name":"Laevers fund for ALS research"},{"DOI":"10.13039\/501100003132","name":"Agentschap voor Innovatie door Wetenschap en Technologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003132","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Saastamoinen foundation","id":[{"id":"https:\/\/ror.org\/03f0nw643","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008413","name":"Instrumentarium Science foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008413","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Finnish Cultural foundation","id":[{"id":"https:\/\/ror.org\/027xav248","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40478-019-0750-2","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T12:02:42Z","timestamp":1562328162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model"],"prefix":"10.1186","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6924-4631","authenticated-orcid":false,"given":"Elisabeth","family":"Rossaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveliina","family":"Pollari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Jaspers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Van Helleputte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Jarpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Van Damme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"De Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Moisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludo","family":"Van Den Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,5]]},"reference":[{"key":"750_CR1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S1474-4422(17)30115-1","volume":"16","author":"K Abe","year":"2017","unstructured":"Abe K, Aoki M, Tsuji S, Itoyama Y, Sobue G, Togo M et al (2017) Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 16:505\u2013512","journal-title":"Lancet Neurol"},{"key":"750_CR2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00401-012-1022-4","volume":"124","author":"A Al-Chalabi","year":"2012","unstructured":"Al-Chalabi A, Jones A, Troakes C, King A, Al-Sarraj S, van den Berg LH (2012) The genetics and neuropathology of amyotrophic lateral sclerosis. Acta Neuropathol 124:339\u2013352","journal-title":"Acta Neuropathol"},{"key":"750_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM et al (2000) Gene ontology: tool for the unification of biology. Nat Genet 25:25\u201329","journal-title":"Nat Genet"},{"key":"750_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00441-016-2463-1","volume":"367","author":"A Aufschnaiter","year":"2017","unstructured":"Aufschnaiter A, Kohler V, Diessl J, Peselj C, Carmona-Gutierrez D, Keller W et al (2017) Mitochondrial lipids in neurodegeneration. Cell Tissue Res 367:125\u2013140","journal-title":"Cell Tissue Res"},{"key":"750_CR5","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1172\/JCI29562","volume":"117","author":"AM Avila","year":"2007","unstructured":"Avila AM, Burnett BG, Taye A, Gabanella F, Knight MA, Hartenstein P et al (2007) Trichostatin a increases SMN expression and survival in a mouse model of spinal muscular atrophy. J Clin Invest 117:659\u2013671","journal-title":"J Clin Invest"},{"key":"750_CR6","doi-asserted-by":"publisher","first-page":"3572","DOI":"10.1172\/JCI79942","volume":"125","author":"E Benito","year":"2015","unstructured":"Benito E, Urbanke H, Ramachandran B, Barth J, Halder R, Awasthi A et al (2015) HDAC inhibitor-dependent transcriptome and memory reinstatement in cognitive decline models. J Clin Invest 125:3572\u20133584","journal-title":"J Clin Invest"},{"key":"750_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.trsl.2018.10.002","volume":"204","author":"SA Bennett","year":"2018","unstructured":"Bennett SA, Tanaz R, Cobos SN, Torrente MP (2018) Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease. Transl Res 204:19\u201330","journal-title":"Transl Res"},{"issue":"2","key":"750_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s13311-016-0501-z","volume":"14","author":"Veronick Benoy","year":"2016","unstructured":"Benoy V, Vanden Berghe P, Jarpe M, Van Damme P, Robberecht W, Van Den Bosch L (2017) Development of improved HDAC6 inhibitors as pharmacological therapy for axonal Charcot\u2013Marie\u2013Tooth disease. Neurotherapeutics 14:417\u2013428.","journal-title":"Neurotherapeutics"},{"key":"750_CR9","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJM199403033300901","volume":"330","author":"G Bensimon","year":"1994","unstructured":"Bensimon G, Lacomblez L, Meininger V (1994) A controlled trial of Riluzole in amyotrophic lateral sclerosis. N Engl J Med 330:585\u2013591","journal-title":"N Engl J Med"},{"key":"750_CR10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/jnc.13035","volume":"133","author":"K Bouyakdan","year":"2015","unstructured":"Bouyakdan K, Ta\u00efb B, Budry L, Zhao S, Rodaros D, Neess D et al (2015) A novel role for central ACBP\/DBI as a regulator of long-chain fatty acid metabolism in astrocytes. J Neurochem 133:253\u2013265","journal-title":"J Neurochem"},{"key":"750_CR11","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1093\/brain\/awt164","volume":"136","author":"G Bruneteau","year":"2013","unstructured":"Bruneteau G, Simonet T, Bauch\u00e9 S, Mandjee N, Malfatti E, Girard E et al (2013) Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression. Brain 136:2359\u20132368","journal-title":"Brain"},{"key":"750_CR12","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1021\/acschemneuro.7b00297","volume":"9","author":"K Chen","year":"2017","unstructured":"Chen K, Bennett SA, Rana N, Yousuf H, Said M, Taaseen S et al (2017) Neurodegenerative disease Proteinopathies are connected to distinct histone post-translational modification landscapes. ACS Chem Neurosci 9:838\u2013848","journal-title":"ACS Chem Neurosci"},{"key":"750_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/17482960802320487","volume":"10","author":"ME Cudkowicz","year":"2009","unstructured":"Cudkowicz ME, Andres PL, Macdonald SA, Bedlack RS, Choudry R, Brown RH Jr et al (2009) Phase 2 study of sodium phenylbutyrate in ALS. Amyotroph Lateral Scler 10:99\u2013106","journal-title":"Amyotroph Lateral Scler"},{"key":"750_CR14","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/nm.2396","volume":"17","author":"C d\u2019Ydewalle","year":"2011","unstructured":"d\u2019Ydewalle C, Krishnan J, Chiheb DM, Van Damme P, Irobi J, Kozikowski AP et al (2011) HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1\u2013induced Charcot-Marie-tooth disease. Nat Med 17:968\u2013974","journal-title":"Nat Med"},{"key":"750_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/17482960802226148","volume":"10","author":"SJ Del Signore","year":"2009","unstructured":"Del Signore SJ, Amante DJ, Kim J, Stack EC, Goodrich S, Cormier K et al (2009) Amyotrophic lateral sclerosis combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice. Amyotroph Lateral Scler 10:85\u201394","journal-title":"Amyotroph Lateral Scler"},{"key":"750_CR16","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/ana.22051","volume":"67","author":"HX Deng","year":"2010","unstructured":"Deng HX, Zhai H, Bigio EH, Yan J, Fecto F, Ajroud K et al (2010) FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann Neurol 67:739\u2013748","journal-title":"Ann Neurol"},{"issue":"11","key":"750_CR17","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1093\/brain\/awx248","volume":"140","author":"Anny Devoy","year":"2017","unstructured":"Devoy A, Kalmar B, Stewart M, Park H, Burke B, Noy SJ et al (2017) Humanized mutant FUS drives progressive motor neuron degeneration without aggregation in \u2018FUSDelta14\u2019 knockin mice. Brain 140:2797-2805","journal-title":"Brain"},{"key":"750_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/acn3.147","volume":"2","author":"A Didonna","year":"2014","unstructured":"Didonna A, Opal P (2014) The promise and perils of HDAC inhibitors in neurodegeneration. Ann Clin Transl Neurol 2:79\u2013101","journal-title":"Ann Clin Transl Neurol"},{"key":"750_CR19","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1038\/ncomms5335","volume":"5","author":"S Dini Modigliani","year":"2014","unstructured":"Dini Modigliani S, Morlando M, Errichelli L, Sabatelli M, Bozzoni I (2014) An ALS-associated mutation in the FUS 3\u2032-UTR disrupts a microRNA\u2013FUS regulatory circuitry. Nat Commun 5:4335","journal-title":"Nat Commun"},{"key":"750_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S et al (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15\u201321","journal-title":"Bioinformatics"},{"key":"750_CR21","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.mcn.2013.03.006","volume":"56","author":"D Dormann","year":"2013","unstructured":"Dormann D, Haass C (2013) Fused in sarcoma (FUS): an oncogene goes awry in neurodegeneration. Mol Cell Neurosci 56:475\u2013486","journal-title":"Mol Cell Neurosci"},{"key":"750_CR22","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/embo-reports\/kvf053","volume":"3","author":"A Eberharter","year":"2002","unstructured":"Eberharter A, Becker PB (2002) Histone acetylation: a switch between repressive and permissive chromatin. EMBO Rep 3:224\u2013229","journal-title":"EMBO Rep"},{"key":"750_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/glia.22902","volume":"64","author":"M Ebrahimi","year":"2016","unstructured":"Ebrahimi M, Yamamoto Y, Sharifi K, Kida H, Kagawa Y, Yasumoto Y et al (2016) Astrocyte-expressed FABP7 regulates dendritic morphology and excitatory synaptic function of cortical neurons. Glia 64:48\u201362","journal-title":"Glia"},{"key":"750_CR24","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3390\/ijms18071414","volume":"18","author":"T Eckschlager","year":"2017","unstructured":"Eckschlager T, Plch J, Stiborova M, Hrabeta J (2017) Histone deacetylase inhibitors as anticancer drugs. Int J Mol Sci 18:1414","journal-title":"Int J Mol Sci"},{"key":"750_CR25","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1073\/pnas.1620506114","volume":"114","author":"HA Ferris","year":"2017","unstructured":"Ferris HA, Perry RJ, Moreira GV, Shulman GI, Horton JD, Kahn CR (2017) Loss of astrocyte cholesterol synthesis disrupts neuronal function and alters whole-body metabolism. Proc Natl Acad Sci U S A 114:1189\u20131194","journal-title":"Proc Natl Acad Sci U S A"},{"key":"750_CR26","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.expneurol.2008.04.019","volume":"212","author":"C Frank","year":"2008","unstructured":"Frank C, Rufini S, Tancredi V, Forcina R, Grossi D, D\u2019Arcangelo G (2008) Cholesterol depletion inhibits synaptic transmission and synaptic plasticity in rat hippocampus. Exp Neurol 212:407\u2013414","journal-title":"Exp Neurol"},{"key":"750_CR27","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/s41467-017-00911-y","volume":"8","author":"W Guo","year":"2017","unstructured":"Guo W, Naujock M, Fumagalli L, Vandoorne T, Baatsen P, Boon R et al (2017) HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients. Nat Commun 8:861","journal-title":"Nat Commun"},{"key":"750_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/417455a","volume":"417","author":"C Hubbert","year":"2002","unstructured":"Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, Nixon A et al (2002) HDAC6 is a microtubule-associated deacetylase. Nature 417:455\u2013458","journal-title":"Nature"},{"key":"750_CR29","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/NEN.0b013e3181ddd404","volume":"69","author":"C Janssen","year":"2010","unstructured":"Janssen C, Schmalbach S, Boeselt S, Sarlette A, Dengler R, Petri S (2010) Differential Histone Deacetylase mRNA Expression Patterns in Amyotrophic Lateral Sclerosis. J Neuropathol Exp Neurol 69:573\u2013581","journal-title":"J Neuropathol Exp Neurol"},{"key":"750_CR30","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/npp.2013.207","volume":"39","author":"J Jochems","year":"2014","unstructured":"Jochems J, Boulden J, Lee BG, Blendy JA, Jarpe M, Mazitschek R et al (2014) Antidepressant-like properties of novel HDAC6-selective inhibitors with improved brain bioavailability. Neuropsychopharmacology 39:389\u2013400","journal-title":"Neuropsychopharmacology"},{"key":"750_CR31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.vascn.2012.08.001","volume":"66","author":"Z Konsoula","year":"2012","unstructured":"Konsoula Z, Barile FA (2012) Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders. J Pharmacol Toxicol Methods 66:215\u2013220","journal-title":"J Pharmacol Toxicol Methods"},{"key":"750_CR32","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1126\/science.1166066","volume":"323","author":"TJ Kwiatkowski","year":"2009","unstructured":"Kwiatkowski TJ, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C et al (2009) Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323:1205\u20131208","journal-title":"Science"},{"key":"750_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuron.2016.02.033","volume":"90","author":"E Lauwers","year":"2016","unstructured":"Lauwers E, Goodchild R, Verstreken P (2016) Membrane lipids in presynaptic function and disease. Neuron 90:11\u201325","journal-title":"Neuron"},{"key":"750_CR34","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3389\/fncel.2013.00243","volume":"7","author":"R Lazo-G\u00f3mez","year":"2013","unstructured":"Lazo-G\u00f3mez R, Ram\u00edrez-Jarqu\u00edn UN, Tovar-y-Romo LB, Tapia R (2013) Histone deacetylases and their role in motor neuron degeneration. Front Cell Neurosci 7:243","journal-title":"Front Cell Neurosci"},{"key":"750_CR35","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.cmet.2017.08.024","volume":"26","author":"L Liu","year":"2017","unstructured":"Liu L, MacKenzie KR, Putluri N, Maleti\u0107-Savati\u0107 M, Bellen HJ (2017) The glia-neuron lactate shuttle and elevated ROS promote lipid synthesis in neurons and lipid droplet accumulation in glia via APOE\/D. Cell Metab 26:719\u2013737","journal-title":"Cell Metab"},{"key":"750_CR36","doi-asserted-by":"publisher","first-page":"17068","DOI":"10.1523\/JNEUROSCI.4067-10.2010","volume":"30","author":"Q Liu","year":"2010","unstructured":"Liu Q, Trotter J, Juan Z, Melinda MP, Cheng H, Jianxin B et al (2010) Neuronal LRP1 knockout in adult mice leads to impaired brain lipid metabolism and progressive, age-dependent synapse loss and neurodegeneration. J Neurosci 30:17068\u201317078","journal-title":"J Neurosci"},{"key":"750_CR37","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.trci.2015.08.001","volume":"1","author":"T Majid","year":"2015","unstructured":"Majid T, Griffin D, Criss Z, Jarpe M, Pautler RG (2015) Pharmocologic treatment with histone deacetylase 6 inhibitor (ACY-738) recovers Alzheimer\u2019s disease phenotype in amyloid precursor protein\/presenilin 1 (APP\/PS1) mice. Alzheimer\u2019s Dement Transl Res Clin Interv 1:170\u2013181","journal-title":"Alzheimer\u2019s Dement Transl Res Clin Interv"},{"key":"750_CR38","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1093\/nar\/gks042","volume":"40","author":"DJ McCarthy","year":"2012","unstructured":"McCarthy DJ, Chen Y, Smyth GK (2012) Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res 40:4288\u20134297","journal-title":"Nucleic Acids Res"},{"key":"750_CR39","doi-asserted-by":"publisher","first-page":"D183","DOI":"10.1093\/nar\/gkw1138","volume":"45","author":"H Mi","year":"2017","unstructured":"Mi H, Huang X, Muruganujan A, Tang H, Mills C, Kang D et al (2017) PANTHER version 11: expanded annotation data from gene ontology and Reactome pathways, and data analysis tool enhancements. Nucleic Acids Res 45:D183\u2013D189","journal-title":"Nucleic Acids Res"},{"key":"750_CR40","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00401-012-1043-z","volume":"125","author":"JC Mitchell","year":"2013","unstructured":"Mitchell JC, McGoldrick P, Vance C, Hortobagyi T, Sreedharan J, Rogelj B et al (2013) Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion. Acta Neuropathol 125:273\u2013288","journal-title":"Acta Neuropathol"},{"key":"750_CR41","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/bjh.12388","volume":"162","author":"S Mithraprabhu","year":"2013","unstructured":"Mithraprabhu S, Khong T, Jones SS, Spencer A (2013) Histone deacetylase (HDAC) inhibitors as single agents induce multiple myeloma cell death principally through the inhibition of class I HDAC. Br J Haematol 162:559\u2013562","journal-title":"Br J Haematol"},{"key":"750_CR42","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1093\/brain\/awp214","volume":"132","author":"M Neumann","year":"2009","unstructured":"Neumann M, Rademakers R, Roeber S, Baker M, Kretzschmar HA, Mackenzie IRA (2009) A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 132:2922\u20132931","journal-title":"Brain"},{"key":"750_CR43","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/toxsci\/kfl068","volume":"93","author":"AJ Olaharski","year":"2006","unstructured":"Olaharski AJ, Ji Z, Woo J-Y, Lim S, Hubbard AE, Zhang L et al (2006) The histone deacetylase inhibitor Trichostatin a has genotoxic effects in human Lymphoblasts in vitro. Toxicol Sci 93:341\u2013347","journal-title":"Toxicol Sci"},{"key":"750_CR44","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/nrneurol.2015.57","volume":"11","author":"X Paez-Colasante","year":"2015","unstructured":"Paez-Colasante X, Figueroa-Romero C, Sakowski SA, Goutman SA, Feldman EL (2015) Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era. Nat Rev Neurol 11:266\u2013279","journal-title":"Nat Rev Neurol"},{"key":"750_CR45","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1007\/s12035-013-8578-4","volume":"49","author":"O Pansarasa","year":"2014","unstructured":"Pansarasa O, Rossi D, Berardinelli A, Cereda C (2014) Amyotrophic lateral sclerosis and skeletal muscle: an update. Mol Neurobiol 49:984\u2013990","journal-title":"Mol Neurobiol"},{"key":"750_CR46","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.nbd.2005.09.013","volume":"22","author":"S Petri","year":"2006","unstructured":"Petri S, Kiaei M, Kipiani K, Chen J, Calingasan NY, Crow JP et al (2006) Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 22:40\u201349","journal-title":"Neurobiol Dis"},{"key":"750_CR47","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ana.21620","volume":"66","author":"S Piepers","year":"2009","unstructured":"Piepers S, Veldink JH, De Jong SW, Van Der Tweel I, Van Der Pol W-L, Uijtendaal EV et al (2009) Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis. Ann Neurol 66:227\u2013234","journal-title":"Ann Neurol"},{"key":"750_CR48","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13395-018-0153-2","volume":"8","author":"E Pigna","year":"2018","unstructured":"Pigna E, Renzini A, Greco E, Simonazzi E, Fulle S, Mancinelli R et al (2018) HDAC4 preserves skeletal muscle structure following long-term denervation by mediating distinct cellular responses. Skelet Muscle 8:6","journal-title":"Skelet Muscle"},{"key":"750_CR49","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.ebiom.2019.01.038","volume":"40","author":"Eva Pigna","year":"2019","unstructured":"Pigna E, Simonazzi E, Sanna K, Bernadzki KM, Proszynski T, Heil C et al (2019) Histone deacetylase 4 protects from denervation and skeletal muscle atrophy in a murine model of amyotrophic lateral sclerosis. EBioMedicine. https:\/\/doi.org\/10.1016\/J.EBIOM.2019.01.038","journal-title":"EBioMedicine"},{"key":"750_CR50","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1172\/JCI72723","volume":"124","author":"H Qiu","year":"2014","unstructured":"Qiu H, Lee S, Shang Y, Wang WY, Au KF, Kamiya S et al (2014) ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. J Clin Invest 124:981\u2013999","journal-title":"J Clin Invest"},{"key":"750_CR51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nn.3584","volume":"17","author":"AE Renton","year":"2014","unstructured":"Renton AE, Chi\u00f2 A, Traynor BJ (2014) State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci 17:17\u201323","journal-title":"Nat Neurosci"},{"key":"750_CR52","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1093\/hmg\/ddq023","volume":"19","author":"M Riessland","year":"2010","unstructured":"Riessland M, Ackermann B, F\u00f6rster A, Jakubik M, Hauke J, Garbes L et al (2010) SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy. Hum Mol Genet 19:1492\u20131506","journal-title":"Hum Mol Genet"},{"key":"750_CR53","doi-asserted-by":"publisher","first-page":"6537","DOI":"10.1093\/emboj\/cdg615","volume":"22","author":"C Rouaux","year":"2003","unstructured":"Rouaux C, Jokic N, Mbebi C, Boutillier S, Loeffler J-P, Boutillier A-L (2003) Critical loss of CBP\/p300 histone acetylase activity by caspase-6 during neurodegeneration. EMBO J 22:6537\u20136549","journal-title":"EMBO J"},{"key":"750_CR54","doi-asserted-by":"publisher","first-page":"5535","DOI":"10.1523\/JNEUROSCI.1139-07.2007","volume":"27","author":"C Rouaux","year":"2007","unstructured":"Rouaux C, Panteleeva I, Ren\u00e9 F, Gonzalez de Aguilar J-L, Echaniz-Laguna A, Dupuis L et al (2007) Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model. J Neurosci 27:5535\u20135545","journal-title":"J Neurosci"},{"key":"750_CR55","first-page":"177","volume":"19","author":"R Rudolf","year":"2016","unstructured":"Rudolf R, Deschenes MR, Sandri M (2016) Neuromuscular junction degeneration in muscle wasting. Curr Opin Clin Nutr Metab Care 19:177\u2013181","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"750_CR56","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/j.1471-4159.2005.03077.x","volume":"93","author":"H Ryu","year":"2005","unstructured":"Ryu H, Smith K, Camelo SI, Carreras I, Lee J, Iglesias AH et al (2005) Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice. J Neurochem 93:1087\u20131098","journal-title":"J Neurochem"},{"key":"750_CR57","doi-asserted-by":"publisher","first-page":"4748","DOI":"10.1093\/hmg\/ddt328","volume":"22","author":"M Sabatelli","year":"2013","unstructured":"Sabatelli M, Moncada A, Conte A, Lattante S, Marangi G, Luigetti M et al (2013) Mutations in the 3\u2032 untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis. Hum Mol Genet 22:4748\u20134755","journal-title":"Hum Mol Genet"},{"key":"750_CR58","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/sj.cdd.4401769","volume":"13","author":"R Saha","year":"2006","unstructured":"Saha R, Pahan K (2006) HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Differ 13:539\u2013550","journal-title":"Cell Death Differ"},{"key":"750_CR59","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1080\/14656566.2017.1319937","volume":"18","author":"H Sawada","year":"2017","unstructured":"Sawada H (2017) Clinical efficacy of edaravone for the treatment of amyotrophic lateral sclerosis. Expert Opin Pharmacother 18:735\u2013738","journal-title":"Expert Opin Pharmacother"},{"key":"750_CR60","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fncel.2014.00025","volume":"8","author":"F Schmitt","year":"2014","unstructured":"Schmitt F, Hussain G, Dupuis L, Loeffler J-P, Henriques A (2014) A plural role for lipids in motor neuron diseases: energy, signaling and structure. Front Cell Neurosci 8:25","journal-title":"Front Cell Neurosci"},{"key":"750_CR61","doi-asserted-by":"publisher","first-page":"E4769","DOI":"10.1073\/pnas.1406162111","volume":"111","author":"CF Sephton","year":"2014","unstructured":"Sephton CF, Tang AA, Kulkarni A, West J, Brooks M, Stubblefield JJ et al (2014) Activity-dependent FUS dysregulation disrupts synaptic homeostasis. Proc Natl Acad Sci U S A 111:E4769\u2013E4778","journal-title":"Proc Natl Acad Sci U S A"},{"key":"750_CR62","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/hmg\/ddx415","volume":"27","author":"E So","year":"2018","unstructured":"So E, Mitchell JC, Memmi C, Chennell G, Vizcay-Barrena G, Allison L et al (2018) Mitochondrial abnormalities and disruption of the neuromuscular junction precede the clinical phenotype and motor neuron loss in hFUSWTtransgenic mice. Hum Mol Genet 27:463\u2013474","journal-title":"Hum Mol Genet"},{"key":"750_CR63","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/nar\/gkp1005","volume":"38","author":"A Spandidos","year":"2010","unstructured":"Spandidos A, Wang X, Wang H, Seed B (2010) PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Res 38:792\u2013799","journal-title":"Nucleic Acids Res"},{"key":"750_CR64","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1111\/j.1460-9568.2004.03765.x","volume":"20","author":"F Sugai","year":"2004","unstructured":"Sugai F, Yamamoto Y, Miyaguchi K, Zhou Z, Sumi H, Hamasaki T et al (2004) Benefit of valproic acid in suppressing disease progression of ALS model mice. Eur J Neurosci 20:3179\u20133183","journal-title":"Eur J Neurosci"},{"issue":"9","key":"750_CR65","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1093\/hmg\/ddt028","volume":"22","author":"Ines Taes","year":"2013","unstructured":"Taes I, Timmers M, Hersmus N, Bento-Abreu A, Van Den Bosch L, Van Damme P et al (2013) Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS. Hum Mol Genet 22:1783\u20131790","journal-title":"Human Molecular Genetics"},{"key":"750_CR66","doi-asserted-by":"publisher","first-page":"D331","DOI":"10.1093\/nar\/gkw1108","volume":"45","author":"The Gene Ontology Consortium","year":"2017","unstructured":"The Gene Ontology Consortium (2017) Expansion of the gene ontology knowledgebase and resources. Nucleic Acids Res 45:D331\u2013D338","journal-title":"Nucleic Acids Res"},{"key":"750_CR67","doi-asserted-by":"publisher","first-page":"15564","DOI":"10.1073\/pnas.0804249105","volume":"105","author":"EA Thomas","year":"2008","unstructured":"Thomas EA, Coppola G, Desplats PA, Tang B, Soragni E, Burnett R et al (2008) The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington\u2019s disease transgenic mice. Proc Natl Acad Sci U S A 105:15564\u201315569","journal-title":"Proc Natl Acad Sci U S A"},{"key":"750_CR68","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1038\/cddis.2014.247","volume":"5","author":"C Valle","year":"2014","unstructured":"Valle C, Salvatori I, Gerbino V, Rossi S, Palamiuc L, Ren\u00e9 F (2014) Tissue-specific deregulation of selected HDACs characterizes ALS progression in mouse models: pharmacological characterization of SIRT1 and SIRT2 pathways. Cell Death Dis 5:1296","journal-title":"Cell Death Dis"},{"key":"750_CR69","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3109\/07853890.2012.665471","volume":"44","author":"T van Langenhove","year":"2012","unstructured":"van Langenhove T, van der Zee J, van Broeckhoven C (2012) The molecular basis of the frontotemporal lobar degeneration\u2013amyotrophic lateral sclerosis spectrum. Ann Med 44:817\u2013828","journal-title":"Ann Med"},{"key":"750_CR70","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.1165942","volume":"323","author":"C Vance","year":"2009","unstructured":"Vance C, Rogelj B, Hortob\u00e1gyi T, De Vos KJ, Nishimura AL, Sreedharan J et al (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323:1208\u20131211","journal-title":"Science"},{"key":"750_CR71","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00401-018-1835-x","volume":"135","author":"T Vandoorne","year":"2018","unstructured":"Vandoorne T, De Bock K, Van Den Bosch L (2018) Energy metabolism in ALS: an underappreciated opportunity? Acta Neuropathol 135:489\u2013509","journal-title":"Acta Neuropathol"},{"key":"750_CR72","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/nn.3514","volume":"16","author":"W-Y Wang","year":"2013","unstructured":"Wang W-Y, Pan L, Su SC, Quinn EJ, Sasaki M, Jimenez JC et al (2013) Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons. Nat Neurosci 16:1383\u20131391","journal-title":"Nat Neurosci"},{"key":"750_CR73","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nature06992","volume":"454","author":"X Wang","year":"2008","unstructured":"Wang X, Arai S, Song X, Reichart D, Du K, Pascual G et al (2008) Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 454:126\u2013130","journal-title":"Nature"},{"key":"750_CR74","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1126\/science.1181046","volume":"326","author":"AH Williams","year":"2009","unstructured":"Williams AH, Valdez G, Moresi V, Qi X, McAnally J, Elliott JL et al (2009) MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 326:1549\u20131554","journal-title":"Science"},{"key":"750_CR75","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-017-0089-1","volume":"6","author":"S-S Yang","year":"2017","unstructured":"Yang S-S, Zhang R, Wang G, Zhang Y-F (2017) The development prospection of HDAC inhibitors as a potential therapeutic direction in Alzheimer\u2019s disease. Transl Neurodegener 6:19","journal-title":"Transl Neurodegener"},{"key":"750_CR76","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.expneurol.2011.06.003","volume":"231","author":"Y-E Yoo","year":"2011","unstructured":"Yoo Y-E, Ko C-P (2011) Treatment with trichostatin a initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis. Exp Neurol 231:147\u2013159","journal-title":"Exp Neurol"},{"key":"750_CR77","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s13238-014-0131-3","volume":"6","author":"J Zhang","year":"2015","unstructured":"Zhang J, Liu Q (2015) Cholesterol metabolism and homeostasis in the brain. Protein Cell 6:254\u2013264","journal-title":"Protein Cell"},{"key":"750_CR78","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/nprot.2017.147","volume":"13","author":"X Zhang","year":"2018","unstructured":"Zhang X, Smits AH, van Tilburg GB, Ovaa H, Huber W, Vermeulen M (2018) Proteome-wide identification of ubiquitin interactions using UbIA-MS. Nat Protoc 13:530\u2013550","journal-title":"Nat Protoc"},{"key":"750_CR79","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1128\/MCB.01154-06","volume":"28","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Kwon S, Yamaguchi T, Cubizolles F, Rousseaux S, Kneissel M et al (2008) Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally. Mol Cell Biol 28:1688\u20131701","journal-title":"Mol Cell Biol"},{"issue":"4","key":"750_CR80","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"Rob Patro","year":"2017","unstructured":"Rob Patro, Geet Duggal, Michael I Love, Rafael A Irizarry, Carl Kingsford, (2017) Salmon provides fast and bias-aware quantification of transcript expression. Nature Methods 14 (4):417-419","journal-title":"Nature Methods"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0750-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-019-0750-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0750-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T13:45:28Z","timestamp":1721483128000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-019-0750-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,5]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["750"],"URL":"https:\/\/doi.org\/10.1186\/s40478-019-0750-2","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,5]]},"assertion":[{"value":"30 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were approved by the ethical committee of the KU Leuven, Belgium (P055\u20132014) and comply with the current laws of Belgium.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MJ is a shareholder of Acetylon Pharmaceuticals, a subsidiary of Celgene. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}